This Warner Bros. Discovery Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
Author: Avi Kapoor | September 16, 2025 10:02am
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
JP Morgan analyst Tessa Romero downgraded Neumora Therapeutics, Inc. (NASDAQ:NMRA) from Neutral to Underweight. Neumora Therapeutics shares closed at $1.52 on Monday. See how other analysts view this stock.
Johnson Rice analyst Charles Meade downgraded Berry Corporation (NASDAQ:BRY) from Buy to Hold and announced a $4 price target. Berry shares closed at $4.01 on Monday. See how other analysts view this stock.
Barclays analyst Warren Ackerman downgraded Haleon plc (NYSE:HLN) from Overweight to Equal-Weight. Haleon shares closed at $9.68 on Monday. See how other analysts view this stock.
Rothschild & Co analyst Ed Vyvyan downgraded Live Nation Entertainment, Inc. (NYSE:LYV) from Buy to Neutral and raised the price target from $144 to $170. Live Nation Entertainment shares closed at $172.38 on Monday. See how other analysts view this stock.
TD Cowen analyst Doug Creutz downgraded Warner Bros. Discovery, Inc. (NASDAQ:WBD) from Buy to Hold and maintained the price target of $14. Warner Bros. Discovery shares closed at $19.48 on Monday. See how other analysts view this stock.
Considering buying WBD stock? Here’s what analysts think:
